Since 1911, Maimonides has been a cornerstone of the Brooklyn community and is the largest hospital in Brooklyn. Over the last century, we’ve become a world-class care center and a vital part of New York City. From the first heart transplant in the U.S. to the first hospital-based Clinical Simulation Center in the Northeast, we are on the cutting edge of innovation.
Many people who have been infected with SARS-Cov-2, the virus that causes COVID-19, are still dealing with symptoms—something known as long-COVID. According to recent data,
Maimonides Health hosted its 16th annual “Cancer Survivors Day” event at Maimonides Park in honor of cancer patients and survivors who have received treatment at the hospital. Following a two-year hiatus due to COVID-19, the annual event returned to celebrate the gift of life and recognizes the adversity patients face during and after their battle with cancer.
Intravenous ketamine has been used as a pain treatment and for anesthesia management for decades, but Dr. Motov’s research shows that nebulized ketamine works a little differently. “Administration of nebulized ketamine has the potential to offer rapid, effective, titratable, and non-invasive analgesia to patients in pain in various clinical settings when ketamine can be used,” Dr. Motov shared. Eligible patients may even be able to manage their own pain using a breath-actuated nebulization.
